David Norman Frick

Title: David Norman Frick: Innovator in HCV Research

Introduction

David Norman Frick is a notable inventor based in Bayside, Wisconsin, recognized for his contributions to the field of antiviral research. He holds a patent that focuses on innovative methods to combat hepatitis C virus (HCV) infections. His work has significant implications for the development of effective antiviral agents.

Latest Patents

Frick's patent, titled "HCV helicase inhibitors and methods of use thereof," discloses thioflavine S and primuline derivatives that inhibit hepatitis C virus helicase and protease activity. This invention is crucial as it interferes with the life cycle of the hepatitis C virus, providing a potential pathway for antiviral treatments. The patent also encompasses pharmaceutical compositions that utilize these compounds for treating HCV infections.

Career Highlights

Throughout his career, David Norman Frick has been associated with prominent research institutions. He has worked at the University of Kansas Medical Center Research Institute and the UWM Research Foundation, Inc. His research has contributed to advancements in understanding and treating viral infections.

Collaborations

Frick has collaborated with esteemed colleagues in his field, including Jeffrey Aube and Brian Scott Jonathan Blagg. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

David Norman Frick's innovative work in HCV research exemplifies the importance of scientific inquiry in developing effective antiviral therapies. His contributions continue to influence the field and offer hope for improved treatment options for those affected by hepatitis C virus infections.